CDKN2A copy number alteration in bladder cancer: Integrative analysis in patient-derived xenografts and cancer patients

CDKN2A copy number alteration in bladder cancer: Integrative analysis in patient-derived xenografts and cancer patients

Bladder cancer (BlCa) is an extensively heterogeneous disease that leads to great variability in tumor evolution scenarios and lifelong patient surveillance, emphasizing the need for modern, minimally invasive precision medicine. Here, we explored the clinical significance of copy number alterations...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria-Alexandra Papadimitriou, Katerina-Marina Pilala, Konstantina Panoutsopoulou, Panagiotis Levis, Georgios Kotronopoulos, Zoi Kanaki, Gedeon Loules, Maria Zamanakou, Dimitrios Linardoutsos, Diamantis C. Sideris, Konstantinos Stravodimos, Apostolos Klinakis, Andreas Scorilas, Margaritis Avgeris
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Molecular Therapy: Oncology
Subjects:
MT: Regular Issue
PDX mouse model
copy number variation
CNV
cfDNA
ctDNA
Online Access:http://www.sciencedirect.com/science/article/pii/S2950329924000602
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2950329924000602

Similar Items